NetworkNewsBreaks

ThursdayJul 23, 2026 9:00 am

NetworkNewsBreaks – BioAdaptives, Inc. (OTC: BDPT) Completes Manufacturing Readiness for Wellness Product Launch

BioAdaptives (OTC: BDPT) a developer of science-driven wellness products, announced it has completed commercial manufacturing and logistics supply chain readiness, positioning the company to begin rolling out its next-generation wellness platforms next month. The company said it spent the past quarter securing standardized raw materials and partnering with GMP-compliant manufacturing facilities to support anticipated demand for its MyndSystem(TM) cognitive performance platform and upcoming Xcellara(TM) cellular wellness products. BioAdaptives (OTC: BDPT) said its dual-platform strategy targets growing global wellness markets through the stimulant-free, WADA-compliant MyndSystem(TM), designed to support cognitive performance during the day and neurological recovery overnight, and the Xcellara(TM) platform,…

Continue Reading

WednesdayJul 22, 2026 11:57 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Publishes Preclinical Data Supporting IV Cancer Therapy 

Oncotelic Therapeutics (OTCQB: OTLC) together with Sapu Nano, announced publication of a peer-reviewed study in Biomedicines detailing the preclinical data supporting Sapu003, its intravenous Deciparticle(TM) formulation of everolimus. The publication outlines the program's absorption, distribution, metabolism, excretion ("ADME"), pharmacokinetics, tissue distribution, GLP toxicology and cGMP manufacturing data, supporting the ongoing Phase 1 clinical evaluation of Sapu003 in patients with advanced solid tumors. According to the company, the formulation is designed to overcome pharmacokinetic limitations associated with oral everolimus while preserving the drug's metabolic profile. The published findings also describe reduced gastrointestinal drug exposure compared with oral everolimus, no treatment-related gastric pathology in repeat-dose GLP toxicology studies and…

Continue Reading

WednesdayJul 22, 2026 9:20 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Sets Aug. 4 Analyst Day to Showcase Blockchain and AI Strategy

Datavault AI (NASDAQ: DVLT) will host its first Analyst and Investor Day in New York City on Aug. 4, 2026, where management plans to outline the company's strategic roadmap and demonstrate technologies supporting its AI-powered data monetization and real-world asset tokenization platform. The event will feature a live demonstration of the Information Data Exchange(R) ("IDE"), updates on the expansion of the SanQtum distributed GPU edge network and details surrounding the pending acquisition and planned integration of the NYIAX advertising exchange into Datavault AI's broader blockchain ecosystem. Management also expects to discuss the commercialization of its tokenization and exchange platforms, including…

Continue Reading

WednesdayJul 22, 2026 9:10 am

NetworkNewsBreaks – American Fusion Inc. (OTC: AMFN) Appoints Chief Revenue Officer to Lead Commercial Strategy

American Fusion (OTC: AMFN) has appointed Alec Rossa as chief revenue officer, tasking the longtime executive with leading the company's global commercial strategy as it advances development of its proprietary Texatron(TM) Fusion Engine(TM). Rossa will oversee customer development, strategic partnerships, government and institutional relationships and commercialization of the company's planned Power-as-a-Service ("PaaS") business model. He previously spent nearly two decades as president and CEO of MD Charlton Ltd., where he expanded the business into Canada's largest national distributor of police and tactical equipment while building relationships across government, defense and public safety organizations. The company said Rossa's experience negotiating complex…

Continue Reading

WednesdayJul 22, 2026 9:00 am

NetworkNewsBreaks – Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) Reports High-Grade Oxide Gold Intercept at Santa Fe

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. Lahontan Gold (TSXV: LG) (OTCQB: LGCXF) announced additional results from its 2026 drilling program at the Santa Fe Mine project in Nevada, highlighted by a geotechnical diamond drill hole at the Calvada deposit that also intersected significant oxide gold mineralization. Hole CAL26-03C returned 30.8 meters grading 0.93 grams per tonne gold equivalent ("Au Eq"), including a higher-grade interval of 10.7 meters grading 2.18 g/t Au Eq. The company said the intercept ranks among the highest-grade results drilled to date within the Central Calvada deposit…

Continue Reading

TuesdayJul 21, 2026 3:20 pm

NetworkNewsBreaks – Beeline Holdings Inc. (NASDAQ: BLNE) Hits Key Milestone, Builds Momentum with AI-Powered Platform

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to home ownership, was recently added as a member of the Russell Microcap Index. An article discussing this highlights the notable milestone for Beeline as it joins a group of small-cap companies tracked by institutional investors and index-linked funds. “Chief Executive Officer Nick Liuzza said the company expects the addition to improve trading liquidity and broaden investor exposure to the business,” reads the article. “Beeline has spent the last several years positioning itself as a technology-focused alternative to traditional mortgage originators. Through its subsidiary, Beeline…

Continue Reading

TuesdayJul 21, 2026 2:58 pm

NetworkNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Eyes First Gold Poor as Production Restart Nears

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) is advancing toward near-term gold production as it prepares to restart operations at its Beacon Gold Mill in Québec’s Abitibi Gold Belt, using a 100,000-metric-ton bulk sample from its Swanson Gold Project as a feed source for its first gold pour. With gold prices remaining well above historical levels, the company expects to benefit from strong margins, supported by a preliminary economic assessment that anticipates a solid return from the operation. Recent high-grade drill results at Swanson, ongoing mill upgrades, and…

Continue Reading

TuesdayJul 21, 2026 1:24 pm

NetworkNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Deploys Cutting-Edge Exploration Technology at Ontario Project

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) recently engaged Stanford University-originated exploration technology company ExploreTech to conduct an independent data review and drill optimization at its Schryburt Lake REE-Niobium Project in Ontario. Using its proprietary engine, which applies probabilistic modeling to identify high-priority exploration targets, ExploreTech will refine the geometry and depth of four key target areas—Goldfinch, Blue Jay, Blackbird and Starling—while optimizing drill collar placement and delivering a phased drilling sequence for Canamera’s planned 1,500-meter, nine-hole helicopter-supported diamond drilling program. The collaboration is intended to…

Continue Reading

TuesdayJul 21, 2026 1:07 pm

NetworkNewsBreaks – VivoSim Labs, Inc. (NASDAQ: VIVS) Announces $4 Million Private Placement

VivoSim Labs, Inc. (NASDAQ: VIVS) announced it has entered into a securities purchase agreement with a single healthcare-focused institutional investor to raise approximately $4 million in gross proceeds through a private placement of 4,705,883 shares of common stock, or common stock equivalents, and accompanying warrants priced at a combined $0.85 per share. The warrants, which are exercisable following shareholder approval and expire five years after their initial exercise date, carry an exercise price of $0.85 per share. The company also agreed, subject to shareholder approval, to amend certain existing May 2024 warrants by reducing their exercise price from $9.60 to $0.85 per share. The offering is…

Continue Reading

TuesdayJul 21, 2026 12:40 pm

NetworkNewsBreaks – Greenwich LifeSciences, Inc. (NASDAQ: GLSI) Highlights Phase 3 Trial Progress and Expanded Study Design

Greenwich LifeSciences (NASDAQ: GLSI) provided an update on its Phase 3 FLAMINGO-01 trial evaluating GLSI-100, an immunotherapy designed to prevent breast cancer recurrence, announcing that the study's Data Safety Monitoring Board recommended the trial continue without modification following its May 2026 review. The company also said regulatory authorities in the U.S. and Europe have supported planned protocol changes that include expanding enrollment to as many as 2,000 patients, increasing enrollment rates by including all HLA types and maintaining enrollment through interim analyses to strengthen the study design and increase the probability of success. Greenwich LifeSciences said more than 1,500 patients…

Continue Reading